Journal
FRONTIERS IN PHYSIOLOGY
Volume 13, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fphys.2022.867921
Keywords
somatopause; osteoarthritis; sarcopenia; growth hormone; acromegaly; growth hormone deficiency (GHD)
Categories
Funding
- NIH [AG059779]
- Ohio University Heritage College of Osteopathic Medicine
- Diabetes Institute at Ohio University
- State of Ohio's Eminent Scholar Program
Ask authors/readers for more resources
Growth hormone has anabolic effects on muscle and bone, and also has metabolic effects in various tissues. It is closely associated with aging, with levels declining as individuals age. Although clinical data is inconclusive, animal models are essential in understanding the molecular mechanisms of growth hormone action.
Growth hormone (GH) is a peptide hormone that can signal directly through its receptor or indirectly through insulin-like growth factor 1 (IGF-1) stimulation. GH draws its name from its anabolic effects on muscle and bone but also has distinct metabolic effects in multiple tissues. In addition to its metabolic and musculoskeletal effects, GH is closely associated with aging, with levels declining as individuals age but GH action negatively correlating with lifespan. GH's effects have been studied in human conditions of GH alteration, such as acromegaly and Laron syndrome, and GH therapies have been suggested to combat aging-related musculoskeletal diseases, in part, because of the decline in GH levels with advanced age. While clinical data are inconclusive, animal models have been indispensable in understanding the underlying molecular mechanisms of GH action. This review will provide a brief overview of the musculoskeletal effects of GH, focusing on clinical and animal models.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available